Publication | Closed Access

Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females

VaccinationVaccine SafetyCervical CancerHuman Papillomavirus VaccinesVaccine TargetImmunologyVaccine TestingPlacebo-controlled TrialVaccine EfficacyChinese MalesPublic HealthPolyvalent VaccineMedicineEpidemiology